Other research grants
GUARD Consortium Grants in Precision Medicine for Metastatic Bladder Cancer
Call aimed at facilitating access to resources for independent clinical and/or translational research for researchers in genitourinary cancer.
Application period
13 March 2025
GUARD Consortium is pleased to announce the GUARD Consortium Grants in Precision Medicine for Metastatic Bladder Cancer, with the aim of facilitating access to research resources for genitourinary cancer researchers.
The call seeks to promote and develop independent clinical and/or translational research projects in the field of genitourinary tumours.
These grants are the first in the grant programme being developed by GUARD Consortium.